Ads
related to: severe asthma attack- What Is E-Asthma?
Visit The Official Patient Site To
Learn About Your Asthma Condition.
- Patient Support Tools
Access Different Asthma Resources
That Are Available To You.
- Pay As Little As $0
Get Information About A Savings
Program & Learn If You Are Eligible
- Find An Asthma Specialist
Take Control Of Your Asthma
Condition & Find A Doctor Near You.
- Sign Up For Email Updates
Receive Personalized Resources For
Your Asthma Journey, Sign Up.
- Self-Injection Option
View Resources & Frequent Questions
About This Self-Admin Injection.
- What Is E-Asthma?
Search results
GSK’s asthma drug shows promise in reducing severe attacks
WHTC 1450 Holland· 5 days ago(Reuters) - GSK's asthma drug met its primary goal of reducing asthma attacks over a 52-week period...
GSK Experimental Drug Reduces Severe Asthma Attacks in Key Trial
Bloomberg· 6 days agoAn experimental drug from GSK Plc reduced asthma attacks in late-stage trials, paving the way for a...
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
Benzinga via Yahoo Finance· 5 days agoTuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...
Asthma Triggers In Homes Can Send Kids to the ER—This Organization Is Working to Change That
Health.com· 5 days agoFor parents of children with asthma, witnessing an attack of severe symptoms can be a terrifying...
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters· 5 days ago, opens new tab experimental drug met its primary goal of reducing asthma attacks in a late-stage...
Manage Your Asthma: FDA on Know Your Triggers and Treatment Options
Sierra Sun Times· 5 days agoAsthma is a chronic lung disease that causes the airways to become inflamed and narrow. Symptoms of...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks via Yahoo Finance· 4 days agoGSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...
GSK finds success in severe asthma drug trials
Becker’s Hospital Review· 5 days agoThe drug candidate, depemokimab, was measured in severe asthma patients with Type 2 inflammation characterized by blood eosinophil count, GSK said in a ...
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
Benzinga via AOL· 4 days agoWednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in...
GSK's Potential Blockbuster Asthma Drug Shows Promise in Latest Trial — 2nd Update
Morningstar· 5 days agoThe British pharmaceutical company's depemokimab drug reduced asthma attacks in late-stage trials for patients with severe eosinophilic ...
Ads
related to: severe asthma attack